The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS).

The author reflects on the results of a study by S. A. Jones and colleagues on the impact of idursulfase in the growth of children with Hunter syndrome. He discusses how the study was conducted which involved male patients aged 8 to 15 who were assessed before and after receiving enzyme replacement therapy with idursulfase. The results reportedly highlighted the importance of growth in Hunter syndrome patients as a parameter of genotype severity and idursulfase response.